Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article

References

• Fields JR, Saikaly SK, Schoch JJ. Intralesional immunotherapy for pediatric warts: a review. Pediatr Dermatol. 2020;37(2):265–271. doi:10.1111/pde.14094
   PubMed Web of Science ®Google Scholar
• Aldahan AS, Mlacker S, Shah VV, Kamath P, Alsaidan M, Samarkandy S. Efficacy of intralesional immunotherapy for treating warts: a review of the literature. Dermatol Ther. 2016;29(3):197–207. doi:10.1111/dth.12352
   PubMed Web of Science ®Google Scholar
• Ju HJ, Park HR, Kim JY, Kim GM, Bae JM, Lee JH. Intralesional immunotherapy for non-genital warts: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 2022;88(6):724–737. doi:10.25259/IJDVL_1369_20
   PubMed Web of Science ®Google Scholar
• Diab N, Atef H, Salah E. Intralesional injection of purified protein derivative in the treatment of viral warts: a pilot study. Egypt J Hosp Med. 2021;85(1):3198–3201. doi:10.21608/ejhm.2021.195432
   Google Scholar
• Gilson R, Nugent D, Werner RN, Ballesteros J, Ross J. 2019 IUSTI-Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020;34(8):1644–1653. doi:10.1111/jdv.16522
   PubMed Web of Science ®Google Scholar
• Kanchana L, Thammarucha S, Suchinwanitnit P, Rutnin S. A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts. J Dermatol Treat. 2022;33(1):23–40. doi:10.1080/09546634.2020.1737635
   PubMed Web of Science ®Google Scholar
• Sindhuja T, Bhari N, Gupta S. Asian guidelines for condyloma acuminatum. J Infect Chemother. 2022;28(7):845–852. doi:10.1016/j.jiac.2022.03.004
   PubMed Web of Science ®Google Scholar
• Mohta A, Sharma MK, Kumari P, Ghiya BC, Mehta RD. An intention-to-treat-analysis of the efficacy of immunotherapy using Mycobacterium w vaccine and purified protein derivative of tuberculin for warts with assessment of improvement in quality of life. Dermatol Pract Con. 2022;12(2):1–7.
   Google Scholar
• Obbus SFV, Barit JJG, Yap-silva C. Efficacy of intralesional purified protein derivative for cutaneous warts: a meta-analysis. Acta Med Philipp. 2019;53(4):360–368. doi:10.47895/amp.v53i4.37
   Google Scholar
• Yang H, Kruh-Garcia N, Dobos K. Purified protein derivatives of tuberculin - past, present, and future. FEMS Immunol Med Microbiol. 2012;66(3):273–280. doi:10.1111/j.1574-695X.2012.01002.x
   PubMedGoogle Scholar
• Amirnia M, Khodaeiani E, Fouladi DF, Masoudnia S. Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: a randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy. J DermatolTreat. 2016;27(2):173–178. doi:10.3109/09546634.2015.1078871
   Google Scholar
• Choudhary D, Piya S. Treatment of warts by immunotherapy using purified protein derivative. Birat J Heal Sci. 2018;3(2):463–467. doi:10.3126/bjhs.v3i2.20961
   Google Scholar
• Kus S, Ergun T, Gun D, Akin O. Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol. 2005;19(4):515–516. doi:10.1111/j.1468-3083.2004.01176.x
   PubMed Web of Science ®Google Scholar
• Mishra A, Shrestha S, K.c. S, Karn D. A prospective clinical study for safety and efficacy of intralesional tuberculin purified protein derivative in treatment of palmoplantar verruca. J Nobel Med Coll. 2022;11(1):12–16. doi:10.3126/jonmc.v11i1.45720
   Google Scholar
• Azab M, El-shabrawy MM, Nafea ER, Nada HA. Measurement of serum interleukin 17 level in patients with genital warts before and after intralesional tuberculin injection. J Men’s Health. 2021;18(1):1.
   Web of Science ®Google Scholar
• Abd-Elazeim FMA, Mohammed GFA, Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J DermatolTreat. 2014;25(3):264–267. doi:10.3109/09546634.2013.768760
   Google Scholar
• Shaheen MA, Salem SAM, Fouad DA, El-Fatah AAA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2015;28(4):194–200. doi:10.1111/dth.12230
   PubMed Web of Science ®Google Scholar
• Abou-Taleb DAE, Abou-Taleb HA, El-Badawy O, Ahmed AO, Hassan AET, Awad SM. Intralesional vitamin D3 versus intralesional purified protein derivative in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2019;32(5):1–6. doi:10.1111/dth.13034
   Web of Science ®Google Scholar
• Sil A, Dasgupta S, Chandra S, Datta A, Banerjee A, Das NK. Changes in cytokine profile with immunotherapy in viral warts using purified protein derivative, mumps measles rubella vaccine, and Mycobacterium w vaccine. Indian J Dermatol. 2021;66(1):67–73. doi:10.4103/ijd.IJD_206_20
   PubMed Web of Science ®Google Scholar
• Johnson S, Roberson P, Horn T. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137(4):451–455.
   PubMedGoogle Scholar
• Ahmed R, Bhadbhade SP, Noojibail B, Shetty SM, Varghese A. Comparative study in efficacy and safety of intralesional injections of vitamin D3, measles rubella (MR) vaccine, and purified protein derivative (PPD) in the management of cutaneous warts. J Cutan Aesthet Surg. 2020;13(4):326–332. doi:10.4103/JCAS.JCAS_39_20
   PubMedGoogle Scholar
• Alajlan A. Intra-lesional injection of tuberculin skin test antigens as an immunotherapy for warts: open label placebo controlled clinical trial. Medical Science. 2020;24:105.
   Web of Science ®Google Scholar
• Awad SM, Gomaa AS, Hassan HA, Tawfik YM. Efficacy of cryotherapy combined with intralesional tuberculin purified protein derivative (PPD) versus intralesional tuberculin PPD monotherapy in the treatment of multiple common warts. Dermatol Ther. 2022;35(4):1–14.
   Web of Science ®Google Scholar
• Awad A, Ismael AF, Sallam M, Abdelgaber S. Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: clinical and dermoscopic evaluation. J Cosmet Dermatol. 2022;21(10):4637–4645. doi:10.1111/jocd.14876
   PubMed Web of Science ®Google Scholar
• Bhalala K, Poojary S, Shah K. Comparative study of efficacy of intralesional purified protein derivative (PPD) versus intralesional measles, mumps, and rubella (MMR) vaccine in management of multiple viral warts. J Cutan Aesthet Surg. 2021;14(4):397. doi:10.4103/JCAS.JCAS_166_19
   PubMedGoogle Scholar
• Bhargava S, Kumar U. Purified protein derivative (PPD) as immunotherapy for warts: how effective is it? Australas J Dermatol. 2019;2019:1.
   Google Scholar
• Chandra S, Sil A, Datta A, Pal S, Das NK. A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with Mycobacterium w vaccine in the treatment of multiple viral warts. Indian J Dermatol Venereol Leprol. 2019;85:355–366. doi:10.4103/ijdvl.IJDVL_549_18
   PubMed Web of Science ®Google Scholar
• Diab N, Atef H. Comparative efficacy of using a combination of intralesional purified protein derivative with low dose isotretinoin in the treatment of recalcitrant common warts. Dermatologic Therapy. 2022;2022:1–8.
   Google Scholar
• Durgadevi S, Shridharan P. Treatment of periungual warts: comparison of topical 5 % 5-fluorouracil and intralesional purified protein derivative in a South Indian teaching hospital. Int J Res Dermatol. 2018;4(4):574–578. doi:10.18203/issn.2455-4529.IntJResDermatol20184464
   Google Scholar
• Eassa BI, Abou-Bakr AA, El-Khalawany MA. Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant women. Dermatol Ther. 2011;24(1):137–143. doi:10.1111/j.1529-8019.2010.01388.x
   PubMed Web of Science ®Google Scholar
• Elela IMA, Elshahid AR, Mosbeh A. Intradermal vs intralesional purified protein derivatives in treatment of warts. Golf J Deramatol Venereol. 2011;18(2):21–26.
   Google Scholar
• Farhana K, Asia AJ. Comparative study of therapeutic efficacy of intralesional vitamin D3 versus intralesional purified protein derivative in the treatment of warts. Int J Sci Res. 2020;4(3):226–231.
   Google Scholar
• Fatima SM, Ejaz A, Anwar A. Comparison of efficacy of intralesional purified protein derivative (PPD) with cryotherapy in the treatment of cutaneous warts. Pakistan Armed Forces Med J. 2019;69(5):965–970.
   Google Scholar
• Fawzy MM, Nofal A, Alakad R. Intralesional antigen immunotherapy for the treatment of plane warts: a comparative study. Dermatol Ther. 2020;33(6). doi:10.1111/dth.13807
   Web of Science ®Google Scholar
• Ghaly NE, El-Ashmawy AA, Abou Zeid M, Shaker ESE. Efficacy and safety of intralesional injection of vitamin D3 versus tuberculin PPD in the treatment of plantar warts: a comparative controlled study. J Cosmet Dermatol. 2021;20(4):1231–1240. doi:10.1111/jocd.13712
   PubMed Web of Science ®Google Scholar
• Ibrahim H, El Taieb M, Nada E, Kamal E. Combined intralesional injection of tuberculin purified protein derivative plus cryotherapy versus each alone in the treatment of multiple common warts. Dermatologic Therapy. 2022;2022:1–6.
   Google Scholar
• Jain S, Marfatia YS. A comparative study of intralesional vitamin D3, measles mumps rubella vaccine, and tuberculin purified protein derivative in the treatment of recalcitrant warts: an approach to solve a therapeutic conundrum. J Clin Aesthet Dermatol. 2021;14(11):26–34.
   PubMedGoogle Scholar
• Jaiswal A, Gupta K, Sharma RP, Bedi G. Immunotherapy with PPD in treatment of warts: an open labelled study from western Uttar Pradesh. Indian J Clin Exp Dermatol. 2019;5(1):41–45. doi:10.18231/2581-4729.2019.0010
   Google Scholar
• Kaimal S, Gopinath H, Premalatha V. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts. Int J Dermatol. 2020;59(6):726–729. doi:10.1111/ijd.14839
   PubMed Web of Science ®Google Scholar
• Milante RR, Venida-Tablizo A, King-Ismael D. Efficacy and safety of single versus multiple intralesional immunotherapy with purified protein derivative (PPD) in the treatment of multiple verruca vulgaris. Int J Dermatol. 2019;58(12):1477–1482. doi:10.1111/ijd.14652
   PubMed Web of Science ®Google Scholar
• Mohammed YF, Ibrahim HS, Elbarbary MA, Elsaie ML. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts. J Cosmet Dermatol. 2020;2020:1–7.
   Google Scholar
• Mohta A, Jain SK, Mehta RD, Arora A. Intralesional purified protein derivative of tuberculin versus intralesional Mycobacterium w vaccine in treatment of recalcitrant extragenital warts: a randomized, single-blinded, comparative study. Indian J Dermatol. 2018;63(2):125–130. doi:10.4103/ijd.IJD_585_17
   PubMedGoogle Scholar
• Moubasher AA, Kolta M, Gaber H. Tuberculin purified protein derivative and cryotherapy in the treatment of genital warts: a randomized controlled trial. Hum Androl. 2021;11(11):1–6. doi:10.21608/ha.2021.61492.1075
   Google Scholar
• Nada HA, El-Shabrawy MM, Ibrahim SH, Azab M. Measurement of serum glutathione peroxidase, catalase and superoxide dismutase concentration in patients with external anogenital warts before and after treatment with intralesional tuberculin purified protein derivative. Andrologia. 2020;52(9):1–6. doi:10.1111/and.13661
   Web of Science ®Google Scholar
• Nimbalkar A, Pande S, Sharma R, Borkar M. Tuberculin purified protein derivative immunotherapy in the treatment of viral warts. Indian J Drugs Dermatol. 2016;2(1):19. doi:10.4103/2455-3972.184103
   Google Scholar
• Nofal A, Yehia E, Khater E, Bessar H. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts. J Am Acad Dermatol. 2020;83(1):208–210. doi:10.1016/j.jaad.2020.01.054
   PubMed Web of Science ®Google Scholar
• Nofal A, Alakad R, Fouda I, Fawzy MM. Intralesional antigen immunotherapy in the treatment of periungual warts. J Cutan Med Surg. 2021;25(3):286–292. doi:10.1177/1203475420988859
   PubMed Web of Science ®Google Scholar
• Nofal AA, Elkholy BM, Abd-Elmonsef ER, Nofal HO. Triple intralesional antigen immunotherapy versus monoantigen in the treatment of multiple recalcitrant warts. Dermatol Ther. 2022;12(5):1225–1237. doi:10.1007/s13555-022-00725-x
   Web of Science ®Google Scholar
• Podder I, Bhattacharya S, Mishra V, Sarkar TK, Chandra S, Sil A. Immunotherapy in viral warts with intradermal Bacillus Calmette-Guerin vaccine versus intradermal tuberculin purified protein derivative: a double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India. Indian J Dermatol Venereol Leprol. 2017;83(3):411. doi:10.4103/0378-6323.193623
   PubMed Web of Science ®Google Scholar
• Pundir M, Singh K, Kanodia S. Efficacy of tuberculin purified protein derivative (PPD) in the treatment of plane warts on face. Medpulse Int Med J. 2018;9(1):71–75. doi:10.26611/10219117
   Google Scholar
• Puri N. A study on the efficacy of immunotherapy with purified protein derivative for the treatment of recalcitrant warts. Int J Curr Res. 2019;2019:3–5.
   Google Scholar
• Raveendra L, Raju B, Dharam KKC, Mohan V, Yadav K. Comparison of purified protein derivative and vitamin D in the treatment of recalcitrant warts. Clin Dermatology Rev. 2021;5(1):54. doi:10.4103/CDR.CDR_51_20
   Google Scholar
• Saoji V, Lade NR, Gadegone R, Bhat A. Immunotherapy using purified protein derivative in the treatment of warts: an open uncontrolled trial. Indian J Dermatol Venereol Leprol. 2016;82(1):42–46. doi:10.4103/0378-6323.171650
   PubMed Web of Science ®Google Scholar
• Sharquie KE, Al-Rawi JR, Noaimi AA, Majly WH. Tuberculin as intralesional therapy for viral warts—single-blind, split, placebo, controlled study. J Cosmet Dermatological Sci Appl. 2016;06(05):191–198.
   Google Scholar
• S G, Kumar A. Intralesional immunotherapy with purified protein derivative antigen in the treatment of multiple cutaneous warts: an open label study in an urban teaching hospital. Int J Res Dermatology. 2020;6(6):739. doi:10.18203/issn.2455-4529.IntJResDermatol20204436
   Google Scholar
• Tawfik NZ, Eyada MM, El Hamid REA, Halim HM. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts. Dermatol Ther. 2022;35(10):e15762. doi:10.1111/dth.15762
   PubMed Web of Science ®Google Scholar
• Wan Ahmad Kammal W, Jamil A, Md Nor N. Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: an assessor-blinded, randomized controlled trial. Dermatologic Therapy. 2021;2021:10–15.
   Google Scholar
• Achdiat PA, Antariksa NC, Rowawi R, Suwarsa O, Hidayat YM, Dwiyana RF. The success of intralesional purified protein derivative immunotherapy in the treatment of anogenital warts: a case report. J Exp Pharmacol. 2022;14:131–135. doi:10.2147/JEP.S347241
   PubMedGoogle Scholar
• Alhashmi S, Sadek A. Case report: successful treatment of giant condyloma acuminata with intralesional injection of purified protein derivative. Open Dermatol J. 2021;15(1):36–38. doi:10.2174/1874372202115010036
   Google Scholar
• Manoj S, Manjunath P, Mallikarjun M. A study to assess the efficacy of intradermal purified protein derivative (PPD) in treatment of multiple warts. Paper Presented in 24th World Congress of Dermatology, Milan, Italy. 2019. https://www.wcd2019milan-dl.org/abstract-book/documents/late-breaking-abstracts/26-medical-therapies-pharmacology/a-study-to-assess-the-55.pdf. Accessed 29 February, 2024.
   Google Scholar
• Nofal A, Fouda I. Switching between intralesional antigens: a promising therapeutic approach for recalcitrant warts. JAAD Case Rep. 2020;6(10):1032–1035. doi:10.1016/j.jdcr.2020.07.045
   PubMedGoogle Scholar
• Al Hamzawi NK, Abdallah MH. Managing recalcitrant warts: facts about Bacillus Calmette-Guerin (BCG), Mycobacterium indicus pranii (Mw vaccine), and purified protein derivative (PPD) as immunotherapy. J cosmet dermatol sci appl. 2018;2018:218–235.
   Google Scholar
• Aktaş H, Ergin C, Demir B, Ekiz Ö. Intralesional vitamin D injection may be an effective treatment option for warts. J Cutan Med Surg. 2016;20(2):118–122. doi:10.1177/1203475415602841
   PubMed Web of Science ®Google Scholar